From: The MedSeq Project: a randomized trial of integrating whole genome sequencing into clinical medicine
 | Both trials | Primary care trial | Cardiology trial |
---|---|---|---|
Inclusion criteria | Patients receiving care from MedSeq Project physician participants | Age 40-65 years | Age 18-90 years |
Generally healthy, in the judgment of the patient’s participating physician | Diagnosis of hypertrophic cardiomyopathy (HCM) or dilated cardiomyopathy (DCM) | ||
No indication for a genetic test | Prior or concurrent targeted genetic testing for HCM or DCM | ||
Exclusion criteria | Clinically significant anxiety (Hospital Anxiety and Depression Scale [HADS] anxiety subscale >14) or depression (HADS depression subscale >16) at baseline assessment | Â | Â |
Presence of cardiovascular disease or diabetes | |||
 | Reported current pregnancy or intention for future conception in the next year of participant or spouse/partner |  |  |